4//SEC Filing
Poddar Richa 4
Accession 0001439222-22-000091
CIK 0001439222other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:17 PM ET
Size
8.4 KB
Accession
0001439222-22-000091
Insider Transaction Report
Form 4
Poddar Richa
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common stock
2022-10-15+5,000→ 9,993 total - Exercise/Conversion
Restricted stock units
2022-10-15−5,000→ 0 total→ Common stock (5,000 underlying) - Tax Payment
Common stock
2022-10-17$27.48/sh−1,485$40,808→ 8,508 total
Footnotes (3)
- [F1]Includes 312 shares purchased through the Company's employee stock purchase plan.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001897274
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 4:17 PM ET
- Size
- 8.4 KB